Fk. Tegtmeyer et al., IN-VITRO MODULATION OF INDUCED NEUTROPHIL ACTIVATION BY DIFFERENT SURFACTANT PREPARATIONS, The European respiratory journal, 9(4), 1996, pp. 752-757
Endotracheal surfactant administration has gained an important role in
the treatment of respiratory failure, Polymorphonuclear neutrophil gr
anulocyte (PMN) activation mediated by chemoattractants, such as inter
leukin-8 (IL-8), neutrophil-activating peptide-2 (NAP-2) and formylate
d bacterial oligopeptides, has been found to be involved in the pathop
hysiology of acute respiratory failure. We investigated potential modu
lating effects of commercial surfactant preparations (Exosurf(R), Alve
ofact(R), Curosurf(R) and Survanta(R)) on spontaneous and chemoattract
ant-induced PMN function, Isolated cytochalasin B (CytB)-treated PMNs
from healthy adults were incubated with increasing concentrations of s
urfactant. The response of the cells was measured in terms of elastase
release from the lysosomes within 30 min. The PMNs showed no direct a
ctivation by any of the surfactants tested, However, when cells were s
timulated with suboptimal dosages of chemokines, such as IL-8 (2 nM) o
r NAP-2 (100 nM), or formyl-methionyl-leucyl-phenylalanine (fMLP) (50
nM), and co-incubated with increasing concentrations of surfactant (0.
05-8 mg . mL(-1)) the release of elastase was markedly modulated depen
ding on the surfactant preparation used, Whilst Exosurf(R) and Alveofa
ct(R) showed only modest effects on the elastase release induced by al
l three mediators, Curosurf(R) and Survanta(R) markedly inhibited the
cellular response in a dose-dependent manner, At concentrations above
1 mg . mL(-1), Curosur(R) and Survanta(R) decreased the IL-8, NAP-2 an
d fMLP-induced elastase release by 83, 67 and 90%, and by 82, 75 and 8
0%, respectively. In conclusion, exogenous surfactant may modulate the
inflammatory response of the airways by affecting the chemoattractant
-induced polymorphonuclear neutrophil activation, Surfactant preparati
ons with inhibiting properties on neutrophil activation may participat
e in the prevention of neutrophil-induced lung damage.